- Home
- HSPO vs SHLT Comparison
HSPO vs SHLT Comparison
Compare HSPO & SHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSPO
- SHLT
- Stock Information
- Founded
- HSPO 2014
- SHLT 1987
- Country
- HSPO United States
- SHLT Israel
- Employees
- HSPO N/A
- SHLT N/A
- Industry
- HSPO Blank Checks
- SHLT Business Services
- Sector
- HSPO Finance
- SHLT Consumer Discretionary
- Exchange
- HSPO Nasdaq
- SHLT Nasdaq
- Market Cap
- HSPO 87.7M
- SHLT 63.6M
- IPO Year
- HSPO 2022
- SHLT N/A
- Fundamental
- Price
- HSPO $11.25
- SHLT $2.74
- Analyst Decision
- HSPO
- SHLT Strong Buy
- Analyst Count
- HSPO 0
- SHLT 1
- Target Price
- HSPO N/A
- SHLT $11.00
- AVG Volume (30 Days)
- HSPO 27.4K
- SHLT 3.2K
- Earning Date
- HSPO 01-01-0001
- SHLT 09-26-2024
- Dividend Yield
- HSPO N/A
- SHLT N/A
- EPS Growth
- HSPO N/A
- SHLT N/A
- EPS
- HSPO 0.33
- SHLT N/A
- Revenue
- HSPO N/A
- SHLT $55,939,000.00
- Revenue This Year
- HSPO N/A
- SHLT N/A
- Revenue Next Year
- HSPO N/A
- SHLT N/A
- P/E Ratio
- HSPO $34.26
- SHLT N/A
- Revenue Growth
- HSPO N/A
- SHLT N/A
- 52 Week Low
- HSPO $10.60
- SHLT $2.60
- 52 Week High
- HSPO $11.25
- SHLT $10.44
- Technical
- Relative Strength Index (RSI)
- HSPO 69.42
- SHLT 37.68
- Support Level
- HSPO $11.17
- SHLT $2.64
- Resistance Level
- HSPO $11.25
- SHLT $2.89
- Average True Range (ATR)
- HSPO 0.00
- SHLT 0.12
- MACD
- HSPO 0.00
- SHLT 0.01
- Stochastic Oscillator
- HSPO 100.00
- SHLT 23.92
About HSPO Horizon Space Acquisition I Corp.
Horizon Space Acquisition I Corp is a blank check company.
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.